The capsules are the generic version of Wyeth’s Effexor XR capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.
Mylan is launching the products under a license agreement with Wyeth, a part of Pfizer.
Currently, Mylan has 164 ANDAs pending FDA approval.